Phase II Trial Assessing the Feasibility and Toxicity of Degarelix in Achieving Prostate Downsizing Prior to Treatment With Permanent Seed Prostate Brachytherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 04 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 02 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
- 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.